Sep 19, 2023 / 03:30PM GMT
Operator
Good morning, and welcome to the Xenon Pharmaceuticals Investor Webinar. Please note, this webcast is being recorded and broadcasted live on the Investors section of Xenon's website. This broadcast is property has been on pharmaceuticals and recording, reproduction or transmission of this call without the expressed written consent of Xenon is strictly prohibited. (Operator Instructions) I would now like to introduce Ian Mortimer, President and CEO of Xenon Pharmaceuticals, who will act as a moderator of today's event. Mr. Mortimer, you may go ahead.
Ian C. Mortimer - Xenon Pharmaceuticals Inc. - President, CEO & Director
Thank you, operator, and good morning, everyone, and thanks for joining us today on our webinar. And apologies for starting a few minutes late. We just had a few technical issues that we were working through. But we will try to have the full 90 minutes because we have a full agenda today. Before we begin, I'll point out that we will be making forward-looking statements, which are based on our current expectations and beliefs. These statements
Xenon Pharmaceuticals Inc XEN1101 and the Major Depressive Disorder (MDD) Landscape: A Discussion with KOLs Transcript
Sep 19, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers